163 related articles for article (PubMed ID: 1770270)
21. Impact of clomiphene citrate during ovarian stimulation on the luteal phase after GnRH agonist trigger.
Derksen L; Tournaye H; Stoop D; Van Vaerenbergh I; Bourgain C; Polyzos NP; Haentjens P; Blockeel C
Reprod Biomed Online; 2014 Mar; 28(3):359-68. PubMed ID: 24456700
[TBL] [Abstract][Full Text] [Related]
22. In vitro fertilisation. A review of drug therapy and clinical management.
Jennings JC; Moreland K; Peterson CM
Drugs; 1996 Sep; 52(3):313-43. PubMed ID: 8875126
[TBL] [Abstract][Full Text] [Related]
23. [Hormone profile and follicle development in ovarian stimulation treatment for in vitro fertilization. II. Prolactin, estradiol and progesterone profile].
Sudik R; Fliess FR; Kunkel S
Zentralbl Gynakol; 1989; 111(9):567-80. PubMed ID: 2500795
[TBL] [Abstract][Full Text] [Related]
24. Combination clomiphene citrate/human menopausal gonadotropin stimulation protocols for in vitro fertilization-embryo transfer.
Hill GA; Diamond MP; Maxson WS; Herbert CM; Webster BW; Vaughn WK; Osteen KG; Rogers BJ; Wentz AC
J In Vitro Fert Embryo Transf; 1987 Feb; 4(1):34-9. PubMed ID: 3108425
[TBL] [Abstract][Full Text] [Related]
25. [Ovarian stimulation and corpus luteum function in human in vitro fertilization and embryo transfer].
Hara S
Nihon Sanka Fujinka Gakkai Zasshi; 1987 Nov; 39(11):2043-50. PubMed ID: 3123577
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of different ovarian stimulation protocols for in vitro fertilization.
Pados G; Tarlatzis BC; Bontis J; Lagos S; Papadimas J; Spanos E; Mantalenakis S
Gynecol Endocrinol; 1995 Jun; 9(2):103-12. PubMed ID: 7502685
[TBL] [Abstract][Full Text] [Related]
27. The influence of transient hyperprolactinemia on in vitro fertilization in humans.
Forman R; Fishel SB; Edwards RG; Walters E
J Clin Endocrinol Metab; 1985 Mar; 60(3):517-22. PubMed ID: 3919045
[TBL] [Abstract][Full Text] [Related]
28. Serum inhibin levels in gonadotrophin stimulated in-vitro fertilization/gamete intra-fallopian transfer cycles.
Urbancsek J; Rabe T; Grunwald K; Kiesel L; Klinga K; Papp Z; Runnebaum B
Hum Reprod; 1992 Oct; 7(9):1195-200. PubMed ID: 1478996
[TBL] [Abstract][Full Text] [Related]
29. The synergistic effects of clomiphene citrate and human menopausal gonadotrophin in the folliculogenesis of stimulated cycles as assessed by the gonadotrophin-releasing hormone antagonist Nal-Glu.
Cassidenti DL; Paulson RJ; Lobo RA; Sauer MV
Hum Reprod; 1992 Mar; 7(3):344-8. PubMed ID: 1587939
[TBL] [Abstract][Full Text] [Related]
30. Anterior pituitary dysfunction during the luteal phase following ovarian hyperstimulation.
Martikainen H; Rönnberg L; Ruokonen A; Kauppila A
Fertil Steril; 1987 Mar; 47(3):446-9. PubMed ID: 3104097
[TBL] [Abstract][Full Text] [Related]
31. Comparison of human menopausal gonadotropin, clomiphene citrate, and combined human menopausal gonadotropin-clomiphene citrate stimulation protocols for in vitro fertilization.
Diamond MP; Hill GA; Webster BW; Herbert CM; Rogers BJ; Osteen KG; Maxson WS; Vaughn WK; Wentz AC
Fertil Steril; 1986 Dec; 46(6):1108-12. PubMed ID: 2946610
[TBL] [Abstract][Full Text] [Related]
32. Clomiphene citrate attenuates hyperprolactinemia associated with ovarian hyperstimulation in the primate menstrual cycle.
Simon JA; Gianfortoni JG; Hodgen GD
J Clin Endocrinol Metab; 1988 Apr; 66(4):811-4. PubMed ID: 3346359
[TBL] [Abstract][Full Text] [Related]
33. A short luteal phase in cycles stimulated with clomiphene and human menopausal gonadotropin for in vitro fertilization.
Laatikainen T; Kurunmäki H; Koskimies A
J In Vitro Fert Embryo Transf; 1988 Feb; 5(1):14-7. PubMed ID: 3130450
[TBL] [Abstract][Full Text] [Related]
34. Follicular phase gonadotropin-releasing hormone agonist and human gonadotropins: a better alternative for ovulation induction in in vitro fertilization.
Garcia JE; Padilla SL; Bayati J; Baramki TA
Fertil Steril; 1990 Feb; 53(2):302-5. PubMed ID: 2105247
[TBL] [Abstract][Full Text] [Related]
35. Comparison of human menopausal gonadotropin and follicle-stimulating hormone with gonadotropin-releasing hormone agonist desensitization for controlled ovarian hyperstimulation in in vitro fertilization.
Yang TS; Wang BC; Chang SP; Ng HT
Zhonghua Yi Xue Za Zhi (Taipei); 1995 Jun; 55(6):452-6. PubMed ID: 7634183
[TBL] [Abstract][Full Text] [Related]
36. Pulsatility of serum-luteinizing hormone during hyperstimulation with clomiphene citrate and human menopausal gonadotropin for in vitro fertilization.
Wolfram J; Siegberg R; Apter D; Alfthan H; Stenman UH; Laatikainen T
Fertil Steril; 1989 Nov; 52(5):817-20. PubMed ID: 2509253
[TBL] [Abstract][Full Text] [Related]
37. Alterations in luteal phase progesterone and estradiol production after leuprolide acetate therapy before ovarian stimulation for in vitro fertilization.
Brzyski RG; Jones GS; Jones HW; Oehninger S; Muasher SJ
Fertil Steril; 1991 Jan; 55(1):119-24. PubMed ID: 1898886
[TBL] [Abstract][Full Text] [Related]
38. Comparative trial of clomiphene citrate/human menopausal gonadotropin and the contraceptive pill, followed by clomiphene citrate/human menopausal gonadotropin, in a gamete intrafallopian transfer program.
Kruger TF; Fisher A; Swart Y; Van der Merwe JP; Smith K
J Assist Reprod Genet; 1993 Feb; 10(2):141-4. PubMed ID: 8339018
[TBL] [Abstract][Full Text] [Related]
39. Short-term endocrine response to gonadotropin-releasing hormone agonist initiated in the early follicular, midluteal, or late luteal phase in normally cycling women.
Gelety TJ; Pearlstone AC; Surrey ES
Fertil Steril; 1995 Dec; 64(6):1074-80. PubMed ID: 7589655
[TBL] [Abstract][Full Text] [Related]
40. Pituitary down-regulation using leuprolide for the intensive ovulation management of poor prognosis patients having in vitro fertilization (IVF)-related treatments.
Cummins JM; Yovich JM; Edirisinghe WR; Yovich JL
J In Vitro Fert Embryo Transf; 1989 Dec; 6(6):345-52. PubMed ID: 2517507
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
